Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | SNRPD2 | Human | (-)-alpha-phellandrene | decreases expression | EXP | | 6480464 | alpha phellandrene results in decreased expression of SNRPD2 mRNA | CTD | PMID:25075043 | SNRPD2 | Human | (1->4)-beta-D-glucan | multiple interactions | ISO | Snrpd2 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SNRPD2 mRNA | CTD | PMID:36331819 | SNRPD2 | Human | 1,2-dimethylhydrazine | multiple interactions | ISO | Snrpd2 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of SNRPD2 mRNA | CTD | PMID:22206623 | SNRPD2 | Human | 1,2-dimethylhydrazine | increases expression | ISO | Snrpd2 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of SNRPD2 mRNA | CTD | PMID:22206623 | SNRPD2 | Human | 2,2',4,4'-Tetrabromodiphenyl ether | affects expression | ISO | Snrpd2 (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:30294300 | SNRPD2 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Snrpd2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of SNRPD2 mRNA | CTD | PMID:21570461 | SNRPD2 | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Snrpd2 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SNRPD2 mRNA | CTD | PMID:33387578 | SNRPD2 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Snrpd2 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of SNRPD2 mRNA | CTD | PMID:34747641 | SNRPD2 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Snrpd2 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SNRPD2 mRNA | CTD | PMID:32109520 | SNRPD2 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Snrpd2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SNRPD2 mRNA | CTD | PMID:15034205 | SNRPD2 | Human | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Snrpd2 (Mus musculus) | 6480464 | AHR protein inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of SNRPD2 mRNA] | CTD | PMID:15034205 | SNRPD2 | Human | 4,4'-sulfonyldiphenol | affects expression | EXP | | 6480464 | bisphenol S affects the expression of SNRPD2 protein | CTD | PMID:31945527 | SNRPD2 | Human | 4,4'-sulfonyldiphenol | increases expression | EXP | | 6480464 | bisphenol S results in increased expression of SNRPD2 protein | CTD | PMID:34186270 | SNRPD2 | Human | acrolein | multiple interactions | EXP | | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of SNRPD2 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of SNRPD2 mRNA | CTD | PMID:32699268 | SNRPD2 | Human | actinomycin D | multiple interactions | EXP | | 6480464 | [Dactinomycin co-treated with nutlin 3] results in increased secretion of SNRPD2 protein | CTD | PMID:38460933 | SNRPD2 | Human | alpha-phellandrene | decreases expression | EXP | | 6480464 | alpha phellandrene results in decreased expression of SNRPD2 mRNA | CTD | PMID:25075043 | SNRPD2 | Human | alpha-pinene | multiple interactions | EXP | | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of SNRPD2 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of SNRPD2 mRNA | CTD | PMID:32699268 | SNRPD2 | Human | Aroclor 1254 | increases expression | ISO | Snrpd2 (Mus musculus) | 6480464 | Chlorodiphenyl (54% Chlorine) results in increased expression of SNRPD2 mRNA | CTD | PMID:23650126 | SNRPD2 | Human | arsenite(3-) | multiple interactions | EXP | | 6480464 | arsenite promotes the reaction [G3BP1 protein binds to SNRPD2 mRNA] | CTD | PMID:32406909 | SNRPD2 | Human | beauvericin | multiple interactions | EXP | | 6480464 | [beauvericin co-treated with enniatins] results in increased expression of SNRPD2 protein | CTD | PMID:32407736 | SNRPD2 | Human | benzatropine | increases expression | EXP | | 6480464 | Benztropine results in increased expression of SNRPD2 protein | CTD | PMID:34122009 | SNRPD2 | Human | benzo[a]pyrene | multiple interactions | ISO | Snrpd2 (Mus musculus) | 6480464 | AHR protein affects the reaction [Benzo(a)pyrene affects the expression of SNRPD2 mRNA] and AHR protein inhibits the reaction [Benzo(a)pyrene results in decreased expression of SNRPD2 mRNA] | CTD | PMID:15034205 and PMID:22228805 | SNRPD2 | Human | benzo[a]pyrene | decreases expression | ISO | Snrpd2 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of SNRPD2 mRNA | CTD | PMID:15034205 | SNRPD2 | Human | benzo[a]pyrene | increases expression | ISO | Snrpd2 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of SNRPD2 mRNA | CTD | PMID:22228805 | SNRPD2 | Human | bisphenol A | affects expression | ISO | Snrpd2 (Rattus norvegicus) | 6480464 | bisphenol A affects the expression of SNRPD2 mRNA | CTD | PMID:25181051 | SNRPD2 | Human | bisphenol A | decreases expression | ISO | Snrpd2 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of SNRPD2 mRNA | CTD | PMID:35598803 | SNRPD2 | Human | bisphenol A | increases expression | ISO | Snrpd2 (Mus musculus) | 6480464 | bisphenol A results in increased expression of SNRPD2 mRNA | CTD | PMID:33221593 | SNRPD2 | Human | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of SNRPD2 mRNA | CTD | PMID:38568856 | SNRPD2 | Human | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of SNRPD2 mRNA | CTD | PMID:30903817 | SNRPD2 | Human | bisphenol F | decreases expression | ISO | Snrpd2 (Mus musculus) | 6480464 | bisphenol F results in decreased expression of SNRPD2 mRNA | CTD | PMID:38685157 | SNRPD2 | Human | cadmium dichloride | decreases methylation | ISO | Snrpd2 (Rattus norvegicus) | 6480464 | Cadmium Chloride results in decreased methylation of SNRPD2 promoter | CTD | PMID:22457795 | SNRPD2 | Human | cadmium dichloride | increases expression | ISO | Snrpd2 (Mus musculus) | 6480464 | Cadmium Chloride results in increased expression of SNRPD2 mRNA | CTD | PMID:24982889 | SNRPD2 | Human | chloropicrin | increases expression | EXP | | 6480464 | chloropicrin results in increased expression of SNRPD2 mRNA | CTD | PMID:26352163 | SNRPD2 | Human | chromium(6+) | affects expression | ISO | Snrpd2 (Mus musculus) | 6480464 | chromium hexavalent ion affects the expression of SNRPD2 mRNA | CTD | PMID:28472532 | SNRPD2 | Human | clobetasol | increases expression | ISO | Snrpd2 (Mus musculus) | 6480464 | Clobetasol results in increased expression of SNRPD2 mRNA | CTD | PMID:27462272 | SNRPD2 | Human | clozapine | increases expression | ISO | Snrpd2 (Mus musculus) | 6480464 | Clozapine results in increased expression of SNRPD2 mRNA | CTD | PMID:14647396 | SNRPD2 | Human | copper atom | decreases expression | ISO | Snrpd2 (Mus musculus) | 6480464 | Copper results in decreased expression of SNRPD2 protein | CTD | PMID:21146535 | SNRPD2 | Human | copper(0) | decreases expression | ISO | Snrpd2 (Mus musculus) | 6480464 | Copper results in decreased expression of SNRPD2 protein | CTD | PMID:21146535 | SNRPD2 | Human | copper(II) sulfate | decreases expression | EXP | | 6480464 | Copper Sulfate results in decreased expression of SNRPD2 mRNA | CTD | PMID:19549813 | SNRPD2 | Human | dibutyl phthalate | decreases expression | ISO | Snrpd2 (Mus musculus) | 6480464 | Dibutyl Phthalate results in decreased expression of SNRPD2 mRNA | CTD | PMID:17361019 and PMID:21266533 | SNRPD2 | Human | dihydroartemisinin | affects binding | EXP | | 6480464 | artenimol analog binds to SNRPD2 protein | CTD | PMID:26340163 | SNRPD2 | Human | enniatin | multiple interactions | EXP | | 6480464 | [beauvericin co-treated with enniatins] results in increased expression of SNRPD2 protein | CTD | PMID:32407736 | SNRPD2 | Human | enzyme inhibitor | multiple interactions | EXP | | 6480464 | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of SNRPD2 protein | CTD | PMID:23301498 | SNRPD2 | Human | epoxiconazole | increases expression | ISO | Snrpd2 (Mus musculus) | 6480464 | epoxiconazole results in increased expression of SNRPD2 mRNA | CTD | PMID:35436446 | SNRPD2 | Human | flutamide | increases expression | ISO | Snrpd2 (Rattus norvegicus) | 6480464 | Flutamide results in increased expression of SNRPD2 mRNA | CTD | PMID:24136188 | SNRPD2 | Human | folic acid | multiple interactions | ISO | Snrpd2 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of SNRPD2 mRNA | CTD | PMID:22206623 | SNRPD2 | Human | folic acid | increases expression | ISO | Snrpd2 (Mus musculus) | 6480464 | Folic Acid results in increased expression of SNRPD2 mRNA | CTD | PMID:25629700 | SNRPD2 | Human | FR900359 | increases phosphorylation | EXP | | 6480464 | FR900359 results in increased phosphorylation of SNRPD2 protein | CTD | PMID:37730182 | SNRPD2 | Human | glafenine | increases expression | ISO | Snrpd2 (Rattus norvegicus) | 6480464 | Glafenine results in increased expression of SNRPD2 mRNA | CTD | PMID:24136188 | SNRPD2 | Human | haloperidol | increases expression | ISO | Snrpd2 (Mus musculus) | 6480464 | Haloperidol results in increased expression of SNRPD2 mRNA | CTD | PMID:14647396 | SNRPD2 | Human | hinokiflavone | increases sumoylation | EXP | | 6480464 | hinokiflavone results in increased sumoylation of SNRPD2 protein | CTD | PMID:28884683 | SNRPD2 | Human | hydralazine | multiple interactions | EXP | | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of SNRPD2 mRNA | CTD | PMID:17183730 | SNRPD2 | Human | ivermectin | decreases expression | EXP | | 6480464 | Ivermectin results in decreased expression of SNRPD2 protein | CTD | PMID:32959892 | SNRPD2 | Human | methyl methanesulfonate | decreases expression | EXP | | 6480464 | Methyl Methanesulfonate results in decreased expression of SNRPD2 mRNA | CTD | PMID:23649840 | SNRPD2 | Human | methylparaben | decreases expression | EXP | | 6480464 | methylparaben results in decreased expression of SNRPD2 mRNA | CTD | PMID:38568856 | SNRPD2 | Human | N-methyl-4-phenylpyridinium | increases expression | ISO | Snrpd2 (Mus musculus) | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of SNRPD2 protein | CTD | PMID:26558463 | SNRPD2 | Human | Nutlin-3 | multiple interactions | EXP | | 6480464 | [Dactinomycin co-treated with nutlin 3] results in increased secretion of SNRPD2 protein | CTD | PMID:38460933 | SNRPD2 | Human | oxaliplatin | multiple interactions | ISO | Snrpd2 (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of SNRPD2 mRNA | CTD | PMID:25729387 | SNRPD2 | Human | ozone | multiple interactions | EXP | | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of SNRPD2 mRNA more ... | CTD | PMID:32699268 | SNRPD2 | Human | ozone | multiple interactions | ISO | Snrpd2 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of SNRPD2 mRNA | CTD | PMID:34911549 | SNRPD2 | Human | ozone | decreases expression | ISO | Snrpd2 (Rattus norvegicus) | 6480464 | Ozone results in decreased expression of SNRPD2 protein | CTD | PMID:33146391 | SNRPD2 | Human | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Snrpd2 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SNRPD2 mRNA | CTD | PMID:36331819 | SNRPD2 | Human | perfluorooctanoic acid | decreases expression | EXP | | 6480464 | perfluorooctanoic acid results in decreased expression of SNRPD2 protein | CTD | PMID:26879310 | SNRPD2 | Human | resveratrol | decreases expression | ISO | Snrpd2 (Mus musculus) | 6480464 | resveratrol results in decreased expression of SNRPD2 protein | CTD | PMID:25505154 | SNRPD2 | Human | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of SNRPD2 mRNA | CTD | PMID:38568856 | SNRPD2 | Human | sodium arsenite | increases expression | EXP | | 6480464 | sodium arsenite results in increased expression of SNRPD2 mRNA | CTD | PMID:34032870 | SNRPD2 | Human | thiram | decreases expression | EXP | | 6480464 | Thiram results in decreased expression of SNRPD2 mRNA | CTD | PMID:38568856 | SNRPD2 | Human | titanium dioxide | decreases expression | ISO | Snrpd2 (Mus musculus) | 6480464 | titanium dioxide analog results in decreased expression of SNRPD2 mRNA | CTD | PMID:25111187 | SNRPD2 | Human | titanium dioxide | decreases methylation | ISO | Snrpd2 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of SNRPD2 gene | CTD | PMID:35295148 | SNRPD2 | Human | toluene | decreases expression | ISO | Snrpd2 (Rattus norvegicus) | 6480464 | Toluene results in decreased expression of SNRPD2 mRNA | CTD | PMID:22967744 | SNRPD2 | Human | topotecan | multiple interactions | ISO | Snrpd2 (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of SNRPD2 mRNA | CTD | PMID:25729387 | SNRPD2 | Human | trimellitic anhydride | increases expression | ISO | Snrpd2 (Mus musculus) | 6480464 | trimellitic anhydride results in increased expression of SNRPD2 mRNA | CTD | PMID:19042947 | SNRPD2 | Human | triphenyl phosphate | affects expression | EXP | | 6480464 | triphenyl phosphate affects the expression of SNRPD2 mRNA | CTD | PMID:37042841 | SNRPD2 | Human | tungsten | increases expression | ISO | Snrpd2 (Mus musculus) | 6480464 | Tungsten results in increased expression of SNRPD2 mRNA | CTD | PMID:30912803 | SNRPD2 | Human | valproic acid | multiple interactions | EXP | | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of SNRPD2 mRNA | CTD | PMID:17183730 | SNRPD2 | Human | valproic acid | increases methylation | EXP | | 6480464 | Valproic Acid results in increased methylation of SNRPD2 gene | CTD | PMID:29154799 | SNRPD2 | Human | vinclozolin | decreases expression | ISO | Snrpd2 (Rattus norvegicus) | 6480464 | vinclozolin results in decreased expression of SNRPD2 mRNA | CTD | PMID:23034163 | |